WHO ICTRP trial

Study to Evaluate the Effect of "Differentiation of Cold and Heat Syndromes"…

ChiCTR2200063205 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2200063205
Public title Study to Evaluate the Effect of "Differentiation of Cold and Heat Syndromes" Combined with Guideline-Directed Medical Treatment on the Quality of Life and Clinical Outcomes in Patients with Early Rheumatoid Arthritis: a Clinical Trial on Constructing a Novel Paradigm of Integrated Traditional Chinese and Western Medici
Scientific title Study to Evaluate the Effect of "Differentiation of Cold and Heat Syndromes" Combined with Guideline-Directed Medical Treatment on the Quality of Life and Clinical Outcomes in Patients with Early Rheumatoid Arthritis: a Clinical Trial on Constructing a Novel Paradigm of Integrated Traditional…
Primary sponsor China-Japan Friendship Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 1
Countries China
Conditions rheumatoid arthritis
Interventions treat group:Guizhi Shaoyao Zhimu Decoction + Methotrexate;control group:Methotrexate
Registration date Sep 1, 2022
Target size treat group:75;control group:75
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations